Vafseo 150 mg, Filmtabletten - 28 Swissmedic Key 68862001 Registration Holder Salmon Pharma GmbH Name Vafseo 150 mg, Filmtabletten Date of registration 19.06.2023 Introduction of Sequence 19.06.2023 ATC-Classification Vadadustat (B03XA08) Revision date WHO WHO-DDD Valid until 18.06.2028 Index Therapeuticus (BSV) Show package size 28 Index Therapeuticus (Swissmedic) 06.07.30. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680688620016 Medication Code Synthetika Pharmacode Disponibility
Composition vadadustatum 150 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 0.38 - 0.58 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Vadadustatum 150 mg
Inactive agents Dose additional_information Carboxymethylamylum Natricum A Cellulosum Microcristallinum E 171 color. Hypromellosum Macrogol 3350 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 07.03.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :